Technology Company Leidos will pour $10 million into a plan to use AI to detect and manage diseases.
The company will work with the University of Pittsburgh Computational Pathology and AI Center of Excellence (CPACE) to develop AI-powered tools for faster detection of diseases, including heart disease and cancer, reducing diagnostic rotation times and enabling faster productive care management.
The alliance aims to establish a research hub at the University of Pittsburgh, to help CPACE develop digital pathology research centers and digital healthcare solutions focused on digital pathology and diagnostics, and to deploy AI-powered digital pathology offerings covering the public and private health sectors.
The two entities will also conduct a collaborative research project to investigate new imaging methods, advanced scanning techniques to analyze tissue samples, and investigate better techniques to analyze medical images.
Additionally, the initiative will include educational programs, symposiums and practical internships that allow students to collaborate with Leidos employees.
“Our investment aims to use the transformational power of artificial intelligence to speed up detection, diagnosis and treatment of diseases that affect millions of people each year,” Leidos CEO Tom Bell said in a statement.
“These efforts will also focus on developing future healthcare professionals and expanding care available to underserved communities, including veterans.”
Bigger trends
Earlier this month, Leidos worked with MoveWorks, the corporate agent AI assistant, to improve efficiency for government workers in the US, UK and Australia.
Agent AI acts as a digital personal assistant who understands how to make decisions and automate daily work processes.
This partnership allows government agencies to adopt technology in security and compliance.
Leidos has announced a new feature from the Sea Systems team called Sea Dart. US Navy and commercial customers for various missions.
Leidos has been awarded a $390 million National Security Agency Intelligence Reporting Agreement to provide the NSA with Signals Intelligence (SIGINT) capabilities, engineering, analysis and reporting tools.
